Israel Chemicals Ltd (NYSE:ICL) Sees Large Decline in Short Interest

Israel Chemicals Ltd (NYSE:ICL) was the target of a significant decrease in short interest during the month of August. As of August 31st, there was short interest totalling 804,300 shares, a decrease of 41.3% from the July 31st total of 1,370,000 shares. Approximately 0.1% of the company’s stock are sold short. Based on an average daily trading volume, of 162,000 shares, the days-to-cover ratio is currently 5.0 days.

Several analysts have commented on ICL shares. Zacks Investment Research raised shares of Israel Chemicals from a “hold” rating to a “strong-buy” rating and set a $6.00 price target for the company in a research report on Friday, June 7th. ValuEngine lowered shares of Israel Chemicals from a “buy” rating to a “hold” rating in a research report on Saturday, June 1st. Three analysts have rated the stock with a hold rating, one has given a buy rating and one has issued a strong buy rating to the company’s stock. Israel Chemicals currently has a consensus rating of “Buy” and an average price target of $5.94.

Shares of ICL stock traded up $0.04 during mid-day trading on Friday, hitting $4.84. 241,700 shares of the stock traded hands, compared to its average volume of 165,894. The stock has a market cap of $6.27 billion, a P/E ratio of 13.08, a P/E/G ratio of 1.19 and a beta of 0.88. The stock’s fifty day moving average is $4.94 and its two-hundred day moving average is $5.20. Israel Chemicals has a 52-week low of $4.43 and a 52-week high of $6.90. The company has a debt-to-equity ratio of 0.53, a current ratio of 1.51 and a quick ratio of 0.85.



Israel Chemicals (NYSE:ICL) last posted its quarterly earnings data on Wednesday, July 31st. The basic materials company reported $0.12 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.11 by $0.01. Israel Chemicals had a net margin of 9.04% and a return on equity of 14.03%. The firm had revenue of $1.43 billion for the quarter, compared to the consensus estimate of $1.44 billion. During the same quarter in the prior year, the company posted $0.09 earnings per share. The company’s revenue for the quarter was up 3.9% compared to the same quarter last year. As a group, equities analysts forecast that Israel Chemicals will post 0.42 EPS for the current fiscal year.

Several institutional investors and hedge funds have recently bought and sold shares of the company. Eaton Vance Management acquired a new position in shares of Israel Chemicals during the second quarter valued at about $58,000. Zacks Investment Management acquired a new position in shares of Israel Chemicals during the second quarter valued at about $98,000. Jane Street Group LLC increased its holdings in shares of Israel Chemicals by 86.0% during the second quarter. Jane Street Group LLC now owns 283,540 shares of the basic materials company’s stock valued at $1,484,000 after acquiring an additional 131,105 shares in the last quarter. Citadel Advisors LLC acquired a new position in shares of Israel Chemicals during the second quarter valued at about $230,000. Finally, Morgan Stanley increased its holdings in shares of Israel Chemicals by 20.4% during the second quarter. Morgan Stanley now owns 92,612 shares of the basic materials company’s stock valued at $481,000 after acquiring an additional 15,701 shares in the last quarter. Hedge funds and other institutional investors own 7.12% of the company’s stock.

Israel Chemicals Company Profile

Israel Chemicals Ltd. operates as a specialty minerals and chemicals company worldwide. It operates in four segments: Industrial Products, Potash, Phosphate Solutions, and Innovative Ag Solutions (IAS). The Industrial Products segment produces bromine out of a solution that is a by-product of the potash production process, as well as bromine-based compounds; produces various grades of potash, salt, magnesium chloride, and magnesia products; and produces and markets phosphorous-based flame retardants and other phosphorus-based products.

Further Reading: S&P 500 Index

Receive News & Ratings for Israel Chemicals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Israel Chemicals and related companies with MarketBeat.com's FREE daily email newsletter.